DRTS

Alpha Tau Medical Ltd. DRTS

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-42.63M

Quarter to Dec 31

Free cash flow

$-32.76M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$119.80M total
Gem Investment Advisors, LLC
$18.05M+1161.2%
HighTower Advisors, LLC
$11.01M0.0%
BOOTHBAY FUND MANAGEMENT, LLC
$9.73MNew
Aquamarine Financial (Cayman) Ltd
$9.08M0.0%
Pier Capital, LLC
$8.70MNew
Fisher Funds Management LTD
$8.41M-5.5%
UBS Group AG
$8.09M+125.0%
Apella Capital, LLC
$4.88M0.0%
LMR Partners LLP
$4.41M+264.9%
ARK Investment Management LLC
$3.49M-5.2%
POLEN CAPITAL MANAGEMENT LLC
$2.78MNew
Mariner, LLC
$2.37M+8.7%
Focus Partners Wealth
$2.32M+472.5%
Daytona Street Capital LLC
$1.83M0.0%
ARISTEIA CAPITAL, L.L.C.
$1.72M+10.8%
Kovitz Investment Group Partners, LLC
$1.70M-8.2%
LEVIN CAPITAL STRATEGIES, L.P.
$1.62M+20.8%
JANE STREET GROUP, LLC
$1.45M+8.4%
WELLS FARGO & COMPANY/MN
$1.37M+139.0%
MMCAP International Inc. SPC
$1.32M0.0%
WOLVERINE ASSET MANAGEMENT LLC
$943.7K+150.1%
CITADEL ADVISORS LLC
$774.4K+73.9%
Dauntless Investment Group, LLC
$769.9KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$689.0K+18.2%
GEODE CAPITAL MANAGEMENT, LLC
$671.8K0.0%
See all 90 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

DRTS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Alpha Tau Medical Ltd. (DRTS): stock profile, AI score and financials

Alpha Tau Medical Ltd. (DRTS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. DRTS is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), Alpha Tau Medical Ltd. reports net income of $-42.6M, free cash flow of $-32.8M. Top institutional holders of DRTS by reported 13-F value include Gem Investment Advisors, HighTower Advisors, BOOTHBAY FUND MANAGEMENT, based on the most recent SEC filings. DRTS trades on the Nasdaq exchange and files with the SEC under CIK 1871321. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DRTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alpha Tau Medical Ltd. directly from SEC EDGAR.

SEC EDGAR: CIK 1871321 →